Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

NCT06623539 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Non Alcoholic Fatty Liver Disease

Interventions

DRUG: Pemafibrate high dose
DRUG: Pemafibrate low dose
DRUG: Fenofibrate

Sponsor

Yokohama City University